The progress of early cancer diagnoses in clinical laboratories
Early diagnosis of cancer is critically important for the ideal prognosis of cancer patients. cfDNA-based new technologies have the potential to be the methodology for liquid biopsy of early cancer patients. Dr Xu Songxiao of Zhejiang Cancer Hospital discusses the progress of cfDNA methylation, fragmentome and microbiome studies, as well as the combined application of […]
The progress of early cancer diagnoses in clinical laboratories Read More »